Shanghai RAAS Blood Products Co., Ltd.
002252
Pozycja w akcjach
#3655
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Cena akcji
$0.70283234
Kapitalizacja rynkowa
$4.63B
Zmiana (1 dzień)
-0.61%
Zmiana (1 rok)
-25.18%
Kraj
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Kategoria
Healthcare
Wskaźnik P/B dla Shanghai RAAS Blood Products Co., Ltd. (002252)
Wskaźnik P/B na dzień October 2026 TTM: 1.01
Według najnowszych raportów finansowych i ceny akcji Shanghai RAAS Blood Products Co., Ltd., obecny wskaźnik P/B (TTM) wynosi 1.01. Na koniec 2023 wynosił 1.70.
Historia wskaźnika P/B dla Shanghai RAAS Blood Products Co., Ltd. od 2005 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 1.01 | -32.79% |
| 2024 | 1.50 | -11.55% |
| 2023 | 1.70 | 14.59% |
| 2022 | 1.48 | -16.45% |
| 2021 | 1.77 | -10.61% |
| 2020 | 1.99 | -39.37% |
| 2019 | 3.27 | -8.41% |
| 2018 | 3.58 | -54.12% |
| 2017 | 7.79 | -19.17% |
| 2016 | 9.64 | -6.16% |
| 2015 | 10.27 | 68.88% |
| 2014 | 6.08 | -86.55% |
| 2013 | 45.24 | 241.08% |
| 2012 | 13.26 | -5.97% |
| 2011 | 14.11 | -38.54% |
| 2010 | 22.95 | 46.93% |
| 2009 | 15.62 | 66.48% |
| 2008 | 9.38 | -68.34% |
| 2007 | 29.64 | 158.32% |
| 2006 | 11.47 | 47.63% |
| 2005 | 7.77 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| 6.251 | 520.02% |
US
|
|
| 13.2547 | 1,214.69% |
US
|
|
| 4.208 | 317.38% |
AU
|
|
| - | - |
CH
|
|
| 6.1824 | 513.21% |
NL
|
